NUVALENT
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. It is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
NUVALENT
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.nuvalent.com
Total Employee:
11+
Status:
Active
Total Funding:
185 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Boundless Bio
Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Cellares
Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Legendairy Foods
Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
nQ Medical
nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.
OnKure Therapeutics
OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
SeylanMED
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis.
Sigilon Therapeutics
Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.
Totient
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.
Tyra Biosciences
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Wellington Management
Wellington Management investment in Series B - Nuvalent
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series B - Nuvalent
Boxer Capital
Boxer Capital investment in Series B - Nuvalent
Viking Global Investors
Viking Global Investors investment in Series B - Nuvalent
Avoro Capital Advisors
Avoro Capital Advisors investment in Series B - Nuvalent
Deerfield
Deerfield investment in Series B - Nuvalent
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Nuvalent
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Nuvalent
Fairmount Funds Management
Fairmount Funds Management investment in Series B - Nuvalent
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Nuvalent
Official Site Inspections
http://www.nuvalent.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.62 K
- Host name: 121.145.67.34.bc.googleusercontent.com
- IP address: 34.67.145.121
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
